Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Mettler-Toledo beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $954.5 million, up 1.3% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and EPS in line with analysts’ estimates.
Is Mettler-Toledo a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Mettler-Toledo’s revenue to grow 7.9% year on year to $1.01 billion, a reversal from the 11.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $11.72 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Mettler-Toledo has missed Wall Street’s revenue estimates three times over the last two years.
Looking at Mettler-Toledo’s peers in the research tools & consumables segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Bio-Techne delivered year-on-year revenue growth of 9%, beating analysts’ expectations by 4.2%, and Danaher reported revenues up 2.1%, topping estimates by 1.6%. Danaher traded down 10% following the results.
Read our full analysis of Bio-Techne’s results here and Danaher’s results here.
There has been positive sentiment among investors in the research tools & consumables segment, with share prices up 2.8% on average over the last month. Mettler-Toledo is up 6.5% during the same time and is heading into earnings with an average analyst price target of $1,344 (compared to the current share price of $1,337).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。